Experience of symptom clusters and the supportive needs of patients undergoing concurrent chemoradiotherapy for cervical cancer: a qualitative study

Author:

Song Zihe1,Jiang Jinxia2,duan xia3,yan xiaoxue1

Affiliation:

1. Shanghai First Maternity and Infant Hospital

2. Shanghai Tenth People's Hospital, Tongji University

3. Tongji University

Abstract

Abstract Purpose To explore the experience of symptom clusters and the current status of supportive need of cervical cancer patients after concurrent chemoradiotherapy and to provide a basis for improving symptom management and social support systems for cervical cancer patients. Methods In this phenomenological study, a total of 13 patients who had undergone concurrent chemoradiotherapy for cervical cancer were selected using a purposive sampling method. From January to October 2022, semi-structured face-to-face interviews were conducted to collect data and a seven-step Colaizzi process was used for data analysis. Results Three themes for the symptom cluster experience were found: declining quality of life, prominent negative emotions, and ineffective response to symptoms. Three themes of patient support needs were identified: mental and psychological needs, medical service needs and desired social support.The subtopics corresponded to these themes. Conclusions Patients with concurrent chemoradiotherapy of cervical cancer have a long disease course, more adverse reactions, and many cluster symptoms, which lead to a high demand for support. Medical staff should strengthen the education of patients about the disease, provide a systematic continuity of care information management platform, establish an effective emotional support system, make comprehensive efforts to reduce the financial burden on patients, promote physical and mental rehabilitation of patients, and improve their quality of life.

Publisher

Research Square Platform LLC

Reference39 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung H;CA Cancer J Clin,2021

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray F;CA Cancer J Clin,2018

3. Cancer statistics in China and United States, 2022:Profiles, trends, and determinants[J];Xia C;Chin Med J(Engl),2022

4. The European society of gynaecological oncology/European society for radiotherapy and oncology/European society of pathology guidelines for the management of patients with cervical cancer;Cibula D;Int J Gynecol Cancer,2018

5. å¤࿽为书,张红ç࿽²,è¢࿽åª࿽.宫é¢࿽ç࿽࿽æ࿽£è࿽࿽å࿽࿽æ­¥æ࿽¾å࿽࿽ç࿽࿽æ࿽࿽é࿽´ç࿽„ç࿽࿽ç࿽¶ç¾¤ä¸࿽ç࿽࿽活质é࿽࿽ç࿽„ç࿽¸å࿽³æ࿽§ç ࿽究[J].é࿽࿽åº࿽å࿽»å­¦,2020,49(03):471–476.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3